Contrafect Obtains $9,997,650 New Financing Round

  • Feed Type
  • Date
    7/4/2013
  • Company Name
    Contrafect
  • Mailing Address
    28 Wells Avenue 3rd Floor Yonkers, NY 10701
  • Company Description
    ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases.
  • Website
    http://www.contrafect.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,997,650
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.